Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
filingDate |
2016-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019501137-A |
titleOfInvention |
4-oxo-4,5-dihydrothiazole derivatives, their preparation and use |
abstract |
The present invention relates to a compound of formula I, a racemate or an optical isomer thereof, or a pharmaceutically acceptable salt, solvate or hydrate thereof, a pharmaceutical composition containing the compound, and a virus. It relates to their use in the manufacture of a medicament for preventing and / or treating a disease or disorder associated with an infection. |
priorityDate |
2015-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |